Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, kicked off its human clinical study, HYPER-H21-1 in 2021, focused on testing its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for the potential use as a hypertension…
Cybercriminals are striking again, reminding the public that they are quick to detect and take advantage of any vulnerabilities left uncovered. A large ransomware campaign has been launched recently to target VMware ESXi hypervisors worldwide,…
Over-the-road shipping technology innovator Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is dedicated to keeping freight moving around the country and between the United States’ primary land-based trading partners in an efficiently designed and successful manner, using…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, today announced its entry into an agreement with GPI Defense, a Houston based provider of custom tailored security…
The Food and Drug Administration (“FDA”) has, over the last two years, authorized several drugs as treatments for mild-to-moderate COVID-19 or as pre-exposure prophylaxis (“PrEP”) for the prevention of the disease. Most of these drugs…
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced new and renewed commercial customer engagements and product updates for its annealing…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) has obtained conditional approval to list its common shares on the Toronto Stock Exchange (“TSX”). According to the announcement, Eloro shares will trade under the trading symbol:…
Golden Matrix Group (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems, and gaming content, is reporting record revenues for its first quarter, ending Jan. 31, 2023. The report…
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced a strategic plan designed to streamline efforts, maximize operating efficiency and focus on critical clinical trials, including near-term, mid-term…
British-Columbia based natural gas operator, EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), has long held aspirations of transforming into Canada’s leading RNG infrastructure platform, in the process securing strong long-term contracted cash flows. The company today…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and…
According to the United States Census Bureau, the export of services under the North American Free Trade Agreement (“NAFTA”), mainly covering transportation, travel, business, and financial services, increased from $14.7 billion in 1999 to $30.4…
Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is focused on retrofitting existing commercial buildings with renewable energy solutions, thereby reducing their carbon footprint…
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The patent, titled…
Pioneering immunotherapy developer BiondVax Pharmaceuticals (NASDAQ: BVXV) is seeing convincingly positive outcomes for preventing and arresting disease in COVID patients during an ongoing preclinical in vivo study, even as continually evolving variants of the COVID…
HeartBeam (NASDAQ: BEAT) CEO and founder Branislav Vajdic, PhD, is featured in a recent interview with David Leichner that was published in “Authority” magazine. The interview was one of a series of interviews with leaders…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional findings from its human clinical study HYPER-H21-4; the study is designed to demonstrate a potentially novel mechanism of action of LEXX’s patented…
FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced the outcome of matters voted on at its recent annual meeting of stockholders, which took place on Feb. 17, 2023. Among the highlights, Hsien…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF) announced that its Sea to Sky Soils organic waste processing and composting facility has entered multiple contracts with a B.C. regional district for the processing of organic waste at the…